Urology | Page 9 of 28 | Links Medicus Content Curation & Alerts in Medicine

In a prospective confirmatory study comparing multiparametric US vs MRI for prostate cancer detection in 306 men with an abnormal PSA or DRE findings, US detected 4.3% fewer clinically significant cancers despite 11.1% more pts being referred for a biopsy: https://t.co/ZFkiUTFJ5Y

— NatureRevClinOncol (@NatRevClinOncol) March 3, 2022

Cancer risks other than female breast and ovarian cancers associated with BRCA1 and BRCA2 pathogenic variants.

3 Mar, 2022 | 08:14h | UTC

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants – Journal of Clinical Oncology

Commentary: Faulty BRCA genes linked to prostate and pancreatic cancers – University of Cambridge

(Epi)genetic predisposing factors found in one-third of children diagnosed with Wilms tumor.

3 Mar, 2022 | 08:10h | UTC

Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization – Journal of Clinical Oncology

Commentary: One third of children with a kidney tumor has hereditary predisposition – Princess Máxima Center for pediatric oncology in Utrecht

M-A: Survival for waitlisted kidney failure patients receiving transplantation vs. remaining on waiting list.

2 Mar, 2022 | 08:46h | UTC

Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis – The BMJ

Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

1 Mar, 2022 | 08:58h | UTC

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

Supportive care needs of men with prostate cancer: A systematic review of qualitative studies.

17 Feb, 2022 | 08:34h | UTC

Supportive care needs of men with prostate cancer: A systematic review update – European Journal of Cancer Care

Arterio-Ureteral Fistula: Systematic Review of 445 Patients.

11 Feb, 2022 | 08:13h | UTC

Arterio-Ureteral Fistula: Systematic Review of 445 Patients – Journal of Urology

M-A: In patients undergoing transperineal prostate biopsy, there was no significant difference in infection, fever, sepsis or readmission rates with vs. without the use of prophylactic antibiotics.

11 Feb, 2022 | 08:16h | UTC

Infection Rate after Transperineal Prostate Biopsy with and without Prophylactic Antibiotics: Results from a Systematic Review and Meta-Analysis of Comparative Studies – Journal of Urology

Randomized trial suggests it is safe to withhold antimicrobial prophylaxis in patients undergoing transurethral resection of the prostate without preoperative pyuria or preoperative indwelling catheter.

9 Feb, 2022 | 08:41h | UTC

Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial – The Journal of Urology (link to abstract – $ for full-text)

AUA/SMSNA Guideline: Disorders of Ejaculation.

7 Feb, 2022 | 08:37h | UTC

Disorders of Ejaculation: An AUA/SMSNA Guideline – American Urological Association

Summary: 2021 CDC guidelines on sexually transmitted infections.

7 Feb, 2022 | 08:33h | UTC

2021 CDC guidelines on sexually transmitted infections – Family Medicine

Original Guideline: CDC releases new guidelines for the treatment of sexually transmitted infections.

ESSM Position Statement: Sexual Wellbeing After Gender Affirming Surgery.

4 Feb, 2022 | 08:34h | UTC

ESSM Position Statement “Sexual Wellbeing After Gender Affirming Surgery” – Sexual Medicine

M-A: Adverse events of immune checkpoint inhibitors therapy for urologic cancer patients in clinical trials.

3 Feb, 2022 | 08:31h | UTC

Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis – European Urology

Commentary on Twitter

Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysishttps://t.co/cnLe3oxATE @ricautor @spsutkaMD @MRoupret @AndreaNecchi @pcvblack pic.twitter.com/EmeapD8O54

— European Urology (@EUplatinum) January 30, 2022